1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Patient clinical outcome dichotomized into good (mRS score, ≤2) and poor clinical outcome (mRS score, >2) at 90 days
Parameters mRS Score ≤2 (n = 38) mRS Score >2 (n = 47) P Value
Age (yr), mean ± SD 65 (±15.7) 74 (±12.7) .0088
NCCT ASPECTS, median (IQR) 9 (7–9) 6 (4–7) <.0001
CBS, median (IQR) 7.5 (6–9) 6 (4–7) .0005
CS, median (IQR) 2.5 (2–3) 2 (1–2.5) .0015
Baseline NIHSS score, median (IQR) 11 (6–16) 19 (15–23) <.0001
rtPA, % (No.) 76.3 (29) 70.0 (31) .3447
rtPA dose (mg), mean ± SD 62.2 ± 14.0 59.2 ± 18.9 .9083
Time to scanning (min), median (IQR) 89 (65–120) 120 (80–150) .0267
Recanalization, % (No.) 57.9 (22) 31.9 (15) .0219
Final infarct size (cm³), mean ± SD 53 ± 72 172 ± 143 <.0001
Baseline CBF (cm³), mean ± SD 85 ± 41 110 ± 56 .0001
Baseline CBV (cm³⁾, mean ± SD 22 ± 16 56 ± 45 .0001
Baseline MTT (cm³), mean ± SD 109 ± 84 84 ± 42 .0344
Note:—NCCT indicates noncontrast CT; IQR, interquartilerange; rtPA, recombinant tissue plasminogen activator.